Inventor
KEVIN J. WILSON
Inventor
US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes27%
C07BGeneral methods of organic chemistry13%
PatentTitleYear
12,595,265Inhibitors of activin receptor-like kinase202612,583,856Inhibitors of protein kinase A202612,441,726Compounds and uses thereof202512,172,983EGFR inhibitors202412,139,487Compounds and uses thereof202411,827,642Compositions useful for treating disorders related to KIT202311,718,602EGFR inhibitors202311,634,422Inhibitors of activin receptor-like kinase202311,279,688Inhibitors of RET2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to BLUEPRINT MEDICINES CORP (7)· patent assignee history
2022–2026Based in US· patent location history
2024–2025Patents assigned to FOGHORN THERAPEUTICS INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BLUEPRINT MEDICINES CORP | 7 | 2022–2026 |
| FOGHORN THERAPEUTICS INC | 2 | 2024–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 9 | 2022–2026 |